Solana lists nine and more $RACE apps; Coinfomania names three
Ferrari’s $RACE token is now live across several applications built on Solana, according to Coinfomania, which cited an announcement shared by Solana’s official account on X. The Ferrari RACE token integration with Solana marks a fresh addition to the network’s growing lineup of supported assets, even as the blockchain’s own price action stays largely flat.
Key takeaways
- Solana’s official X account listed nine apps and more for Ferrari’s $RACE token; Coinfomania named TryFomo, Dflow and Raydium.
- Solana’s official X account confirmed the rollout in a post referenced by Coinfomania.
- Solana’s price held steady with no trading volume logged in the prior 24 hours.
- The Solana Foundation remains the body overseeing the network’s ecosystem development.
Ferrari’s $RACE Token Lands on Solana Apps
The Ferrari $RACE token can now be accessed through Solana-based platforms, expanding where holders can put the asset to use. Coinfomania reported that the move was flagged through a post on Solana’s official Twitter/X account, which named the specific apps now carrying support for the token.
Solana’s official X post lists TryFomo, Dflow, Titan Exchange, Phantom, Jupiter Exchange, Raydium, Archer Exchange, Kamino Swap and Mayan, followed by “and more”; Coinfomania names TryFomo, Dflow and Raydium.
Solana’s price remained stable with no trading volume recorded over the previous 24 hours, Coinfomania noted. The absence of volume sits alongside the token integration news, and oversight of the broader network continues to fall under the Solana Foundation, which supports the ecosystem’s development.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly
XRP Ledger adds account control feature, enabling enterprises to manage assets offline.
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)
Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.
Crypto prices
More
